Skip to content

Clinical trials

Generalized Anxiety Disorder trials in Mexico

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Generalized Anxiety Disorder Country / region: Mexico Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20091
20101
20161
20192
20211
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Unknown status2
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.2
AstraZeneca1
Coordinación de Investigación en Salud, Mexico1
Eli Lilly and Company1
Hospital Universitario Dr. Jose E. Gonzalez1
Instituto Nacional de Psiquiatría Dr. Ramón de la Fuente1
Psicofarma, S.A. De C.V.1
Universidad Autonoma de Baja California1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Generalized Anxiety Disorder9
Anxiety Disorders5
Major Depressive Disorder1
Obsessive-Compulsive Disorder1
Phobia, Social1
Stress Disorders, Post-Traumatic1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.